ES2073245T3 - Agentes para el tratamiento de la cornea. - Google Patents

Agentes para el tratamiento de la cornea.

Info

Publication number
ES2073245T3
ES2073245T3 ES92303380T ES92303380T ES2073245T3 ES 2073245 T3 ES2073245 T3 ES 2073245T3 ES 92303380 T ES92303380 T ES 92303380T ES 92303380 T ES92303380 T ES 92303380T ES 2073245 T3 ES2073245 T3 ES 2073245T3
Authority
ES
Spain
Prior art keywords
cornea
treatment
compositions
therapy
aliphatic alcohols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92303380T
Other languages
English (en)
Inventor
David F Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Technology Inc
Original Assignee
Summit Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Technology Inc filed Critical Summit Technology Inc
Application granted granted Critical
Publication of ES2073245T3 publication Critical patent/ES2073245T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE MUESTRAN COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN ALCOHOLES ALIFATICOS PARA USO EN TERAPIA, POR EJEMPLO TERAPIA OCULAR Y EN PARTICULAR PARA EL TRATAMIENTO DE MOLESTIAS Y ARTEFACTOS VISUALES CONSECUENCIA DE PROCEDIMIENTOS QUIRURGICOS LASER EN LA CORNEA DEL OJO. ESTAS COMPOSICIONES REDUCEN LA INFLAMACION ASOCIADA CON QUERATECTOMIA FOTOREACTIVA E IMPULSAN EL RECRECIMIENTO DEL TEJIDO EPITELIAL SOBRE LA SUPERFICIE DE LA CORNEA REPERFILADA. LAS COMPOSICIONES PUEDEN COMPRENDER ALCOHOLES CON UNA LONGITUD DE CADENA QUE VA DESDE C PUEDEN INCLUIR DOCOSANOL, TETRACOSANOL HEXACOSANOL, O MEZCLAS DE ELLOS.
ES92303380T 1991-04-23 1992-04-15 Agentes para el tratamiento de la cornea. Expired - Lifetime ES2073245T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/690,081 US5098896A (en) 1991-04-23 1991-04-23 Corneal treatment agents

Publications (1)

Publication Number Publication Date
ES2073245T3 true ES2073245T3 (es) 1995-08-01

Family

ID=24771001

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92303380T Expired - Lifetime ES2073245T3 (es) 1991-04-23 1992-04-15 Agentes para el tratamiento de la cornea.

Country Status (9)

Country Link
US (1) US5098896A (es)
EP (1) EP0514009B1 (es)
JP (1) JPH0672865A (es)
AT (1) ATE119769T1 (es)
AU (1) AU662315B2 (es)
CA (1) CA2066842A1 (es)
DE (1) DE69201674T2 (es)
DK (1) DK0514009T3 (es)
ES (1) ES2073245T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271939A (en) * 1988-10-03 1993-12-21 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
ATE399004T1 (de) * 1993-12-13 2008-07-15 Avanir Pharmaceuticals Formulierungen aus c-20 bis c-28 alkoholen und saccharoseestern
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584115A (en) * 1968-05-31 1971-06-08 Arthur Ira Gebhart Method of applying visible aerosol compositions
SE375007B (es) * 1972-11-30 1975-04-07 Pharmacia Ab
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4874794A (en) * 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment

Also Published As

Publication number Publication date
DK0514009T3 (da) 1995-08-07
ATE119769T1 (de) 1995-04-15
AU1217392A (en) 1992-10-29
DE69201674D1 (de) 1995-04-20
EP0514009B1 (en) 1995-03-15
JPH0672865A (ja) 1994-03-15
AU662315B2 (en) 1995-08-31
CA2066842A1 (en) 1992-10-24
DE69201674T2 (de) 1995-10-26
EP0514009A1 (en) 1992-11-19
US5098896A (en) 1992-03-24

Similar Documents

Publication Publication Date Title
ES2182899T3 (es) Formulacion farmaceutica para la administracion subcutanea, intramuscular o intradermica de factor viii.
ATE185063T1 (de) Überlappender ring für die einstellung der hornhautkrümmung
DK1075265T3 (da) Anvendelse af tetracycliner til behandling af sygdom i de Meibomske kirtler
FI901706A0 (fi) Yhtenäinen, kertakäyttöinen, absorboiva tuote
ES2193901T1 (es) Derivados de prostaglandina para el tratamiento de glaucoma o hipertension ocular.
ATE274918T1 (de) Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen
ATE353671T1 (de) Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz,zur behandlung und reparation von bindegeweben in menschen und tieren
ES2091262T3 (es) Uso de magnesio-piridoxal-5'-fosfato-glutaminato para la prevencion de enfermedades que resultan de lesiones vasculares.
ES2143467T3 (es) Agente terapeutico para el tratamiento de las heridas.
DE69105349D1 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
ES2073245T3 (es) Agentes para el tratamiento de la cornea.
DK0790056T3 (da) Anvendelse af præparat til forebyggelse eller behandling af sygdomme forårsaget af abnormiteter i bruskvæv
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
ES2145902T3 (es) Aplicacion del riluzole en el tratamiento de las enfermedades mitocondriales.
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.
ES2182840T3 (es) Factor xiii para el tratamiento de heridas de la piel.
KR930021214A (ko) 안질환의 치료 또는 예방을 위한 제약학적 조성물
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
EP0453337A3 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmic use
DE69307197D1 (de) Verwendung von 24,25-Dihydroxyvitamin-D3 zur Herstellung eines Arzneimittel zur Behandlung der Rachitis
RU94022797A (ru) Способ хирургической коррекции миопической анизометропии
聂纯一 et al. CLINICAL OBSERVATION ON THE EFFICACY OF 764-1 EYEDROPS IN TREATMENT OF CORNEAL SCARS
Fox Trauma and the Eye: Some Occupational Eye Hazards
Davenport The windshield injury